These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 33043516)

  • 21. Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.
    McDonald ER; de Weck A; Schlabach MR; Billy E; Mavrakis KJ; Hoffman GR; Belur D; Castelletti D; Frias E; Gampa K; Golji J; Kao I; Li L; Megel P; Perkins TA; Ramadan N; Ruddy DA; Silver SJ; Sovath S; Stump M; Weber O; Widmer R; Yu J; Yu K; Yue Y; Abramowski D; Ackley E; Barrett R; Berger J; Bernard JL; Billig R; Brachmann SM; Buxton F; Caothien R; Caushi JX; Chung FS; Cortés-Cros M; deBeaumont RS; Delaunay C; Desplat A; Duong W; Dwoske DA; Eldridge RS; Farsidjani A; Feng F; Feng J; Flemming D; Forrester W; Galli GG; Gao Z; Gauter F; Gibaja V; Haas K; Hattenberger M; Hood T; Hurov KE; Jagani Z; Jenal M; Johnson JA; Jones MD; Kapoor A; Korn J; Liu J; Liu Q; Liu S; Liu Y; Loo AT; Macchi KJ; Martin T; McAllister G; Meyer A; Mollé S; Pagliarini RA; Phadke T; Repko B; Schouwey T; Shanahan F; Shen Q; Stamm C; Stephan C; Stucke VM; Tiedt R; Varadarajan M; Venkatesan K; Vitari AC; Wallroth M; Weiler J; Zhang J; Mickanin C; Myer VE; Porter JA; Lai A; Bitter H; Lees E; Keen N; Kauffmann A; Stegmeier F; Hofmann F; Schmelzle T; Sellers WR
    Cell; 2017 Jul; 170(3):577-592.e10. PubMed ID: 28753431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide application of RNAi to the discovery of potential drug targets.
    Ito M; Kawano K; Miyagishi M; Taira K
    FEBS Lett; 2005 Oct; 579(26):5988-95. PubMed ID: 16153642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deconvolution of seed and RNA-binding protein crosstalk in RNAi-based functional genomics.
    Suzuki HI; Spengler RM; Grigelioniene G; Kobayashi T; Sharp PA
    Nat Genet; 2018 May; 50(5):657-661. PubMed ID: 29662165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seed-effect modeling improves the consistency of genome-wide loss-of-function screens and identifies synthetic lethal vulnerabilities in cancer cells.
    Jaiswal A; Peddinti G; Akimov Y; Wennerberg K; Kuznetsov S; Tang J; Aittokallio T
    Genome Med; 2017 Jun; 9(1):51. PubMed ID: 28569207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNAi as a gene therapy approach.
    Caplen NJ
    Expert Opin Biol Ther; 2003 Jul; 3(4):575-86. PubMed ID: 12831363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vector-based RNA interference to study gene function in cancer.
    Stovall DB; Wan M; Zhang Q; Dubey P; Sui G
    J Vis Exp; 2012 Jun; (64):e4129. PubMed ID: 22710444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-Scale RNA Interference Screening to Identify Transcriptional Regulators of a Tumor Suppressor Gene.
    Forloni M; Ho T; Sun L; Wajapeyee N
    Methods Mol Biol; 2017; 1507():261-268. PubMed ID: 27832546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
    Zhang Y; Boado RJ; Pardridge WM
    J Gene Med; 2003 Dec; 5(12):1039-45. PubMed ID: 14661179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular-targeting therapies against quantitative abnormalities in gene expression with malignant tumors.
    Sakai T; Sowa Y
    Cancer Sci; 2017 Apr; 108(4):570-573. PubMed ID: 28178388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
    Zhang Z; Lee JH; Ruan H; Ye Y; Krakowiak J; Hu Q; Xiang Y; Gong J; Zhou B; Wang L; Lin C; Diao L; Mills GB; Li W; Han L
    Nat Commun; 2019 Oct; 10(1):4562. PubMed ID: 31594934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
    Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA: a small molecule with a big biological impact.
    Zhou X; Yang PC
    Microrna; 2012; 1(1):1. PubMed ID: 25048083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.
    Krill-Burger JM; Dempster JM; Borah AA; Paolella BR; Root DE; Golub TR; Boehm JS; Hahn WC; McFarland JM; Vazquez F; Tsherniak A
    Genome Biol; 2023 Aug; 24(1):192. PubMed ID: 37612728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A computational study of off-target effects of RNA interference.
    Qiu S; Adema CM; Lane T
    Nucleic Acids Res; 2005; 33(6):1834-47. PubMed ID: 15800213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer.
    Singel SM; Cornelius C; Batten K; Fasciani G; Wright WE; Lum L; Shay JW
    Clin Cancer Res; 2013 Apr; 19(8):2061-70. PubMed ID: 23479679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput selection of effective RNAi probes for gene silencing.
    Kumar R; Conklin DS; Mittal V
    Genome Res; 2003 Oct; 13(10):2333-40. PubMed ID: 14525931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
    Nakata Y; Kim TK; Shetzline S; Gewirtz AM
    Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional genomics using high-throughput RNA interference.
    Vanhecke D; Janitz M
    Drug Discov Today; 2005 Feb; 10(3):205-12. PubMed ID: 15708535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The silent revolution: RNA interference as basic biology, research tool, and therapeutic.
    Dykxhoorn DM; Lieberman J
    Annu Rev Med; 2005; 56():401-23. PubMed ID: 15660519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.